Effect of spironolactone on monocyte subsets in atrial fibrillation: IMPRESS-AF randomised controlled trial
Article 2025 en
Authors
FS
Farhan Shahid
ES
Eduard Shantsila
AS
Alena Shantsila
Abstract
1 min read
Spironolactone temporarily reduced proinflammatory monocyte markers (Mon3 count and CD14 expression on Mon1). Mon1 may have a positive effect on diastolic dysfunction in AF.
Eduard Shantsila, Farhan Shahid, Yongzhong Sun, Jonathan J Deeks, Melanie Calvert, James P. Fisher, Paulus Kirchhof, Paramjit Gill, Professor Gregory Lip
Eduard Shantsila, Farhan Shahid, Yongzhong Sun, Jonathan J Deeks, Ronnie Haynes, Melanie Calvert, James P. Fisher, Paulus Kirchhof, Paramjit Gill, Professor Gregory Lip
Discussion(0)
No comments yet. Be the first to comment.